Scott Bizily
General Counsel at 4D Molecular Therapeutics, Inc. (FDMT)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $388K
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Sep 22SEC | FDMT4D Molecular Therapeutics, Inc. | Sell Plan | 1,6358,617 held (−16%) | $13.65 | $22K | -2.3% |
| Sep 3SEC | FDMT4D Molecular Therapeutics, Inc. | Sell Plan | 5848,617 held (−6%) | $14.00 | $8K | -4.8% |
| Aug 17SEC | FDMT4D Molecular Therapeutics, Inc. | Sell Plan | 1,6358,617 held (−16%) | $12.00 | $20K | +11.1% |
| Aug 17SEC | FDMT4D Molecular Therapeutics, Inc. | Sell Plan | 1,6358,617 held (−16%) | $12.20 | $20K | +9.3% |
| Jul 2SEC | FDMT4D Molecular Therapeutics, Inc. | Sell Plan | 6,5668,617 held (−43%) | $14.00 | $92K | -4.8% |
| Jun 25SEC | FDMT4D Molecular Therapeutics, Inc. | Sell Plan | 9,8108,617 held (−53%) | $12.00 | $118K | +11.1% |
| Dec 19SEC | FDMT4D Molecular Therapeutics, Inc. | Sell Plan | 1,6353,594 held (−31%) | $10.90 | $18K | +22.3% |
| Nov 19SEC | FDMT4D Molecular Therapeutics, Inc. | Sell Plan | 1,6353,594 held (−31%) | $10.59 | $17K | +25.9% |
| Oct 27SEC | FDMT4D Molecular Therapeutics, Inc. | Sell Plan | 2,6783,594 held (−43%) | $12.00 | $32K | +11.1% |
| Oct 20SEC | FDMT4D Molecular Therapeutics, Inc. | Sell Plan | 1,6355,188 held (−24%) | $10.17 | $17K | +31.1% |
| Oct 14SEC | FDMT4D Molecular Therapeutics, Inc. | Sell Plan | 2,4085,188 held (−32%) | $10.00 | $24K | +33.3% |
- Sell
General Counsel Scott Bizily sold $22K of FDMT at $13.65 — pre-scheduled 10b5-1 plan sale.
- Sell
General Counsel Scott Bizily sold $8K of FDMT at $14.00 — pre-scheduled 10b5-1 plan sale.
- Sell
General Counsel Scott Bizily sold $20K of FDMT at $12.00 — pre-scheduled 10b5-1 plan sale.
- Sell
General Counsel Scott Bizily sold $20K of FDMT at $12.20 — pre-scheduled 10b5-1 plan sale.
- Sell
General Counsel Scott Bizily sold $92K of FDMT at $14.00 — cuts the stake by 43%; pre-scheduled 10b5-1 plan sale.
- Sell
General Counsel Scott Bizily sold $118K of FDMT at $12.00 — cuts the stake by 53%; pre-scheduled 10b5-1 plan sale.